Cargando…

mRNA vaccines: A matter of delivery

Detalles Bibliográficos
Autores principales:	Cao, Yuhong, Gao, George F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889829/ https://www.ncbi.nlm.nih.gov/pubmed/33644722 http://dx.doi.org/10.1016/j.eclinm.2021.100746

Ejemplares similares

A Tolerizing mRNA Vaccine against Autoimmunity?
por: Furlan, Roberto
Publicado: (2021)

mRNA, the beginning of a new influenza vaccine game
por: Pecetta, Simone, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Debunking mRNA Vaccine Misconceptions—An Overview for Medical Professionals
por: Hitti, Frederick L., et al.
Publicado: (2021)

Uveitis following mRNA COVID-19 vaccination: Is it real?
por: Murugan, Sivaraman Bala, et al.
Publicado: (2023)

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies
por: Crombie, Jennifer L., et al.
Publicado: (2021)

The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism
por: Lazaros, George, et al.
Publicado: (2021)

Delivery Strategies for mRNA Vaccines
por: Ramachandran, Sivakumar, et al.
Publicado: (2022)

The Delivery of mRNA Vaccines for Therapeutics
por: Nitika,, et al.
Publicado: (2022)

Unveiling the intricacies of gene delivery: Caveolae-mediated endocytosis induces efficient mRNA delivery in slow-dividing cells
por: den Roover, Sabine, et al.
Publicado: (2023)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Overcoming the challenge of long-term storage of mRNA-lipid nanoparticle vaccines
por: Young, Rachel E., et al.
Publicado: (2022)

mRNA Vaccines for COVID-19: A Simple Explanation
por: Hendaus, Mohamed A., et al.
Publicado: (2021)

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021)

A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer
por: Kang, Ning, et al.
Publicado: (2023)

Cell fate conversion by mRNA
por: Li, Mo, et al.
Publicado: (2011)

Low-dose single-shot COVID-19 mRNA vaccines lie ahead
por: Sanders, Niek N.
Publicado: (2021)

Development and Delivery Systems of mRNA Vaccines
por: Liang, Yongjun, et al.
Publicado: (2021)

Nanomaterial Delivery Systems for mRNA Vaccines
por: Buschmann, Michael D., et al.
Publicado: (2021)

Addressing the Cold Reality of mRNA Vaccine Stability
por: Crommelin, Daan J.A., et al.
Publicado: (2021)

What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
por: Silvestris, Nicola
Publicado: (2021)

Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines
por: Kelso, John M.
Publicado: (2021)

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
por: Bolze, Alexandre, et al.
Publicado: (2022)

Understanding the variability of pharmaco‐epidemiological studies assessing the risk of appendicitis with mRNA COVID‐19 vaccines
por: Jambon‐Barbara, Clement, et al.
Publicado: (2022)

Corrigendum: Development and Delivery Systems of mRNA Vaccines
por: Liang, Yongjun, et al.
Publicado: (2021)

Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
por: Wadhwa, Abishek, et al.
Publicado: (2020)

Development of mRNA Vaccines/Therapeutics and Their Delivery System
por: Son, Sora, et al.
Publicado: (2023)

Matrin 3 and HIV Rev Regulation of mRNA
por: Dayton, Andrew I
Publicado: (2011)

Diagnosis of Acute Myocarditis Following mRNA Vaccines against SARS-CoV-2: A Methodological Review
por: Zuin, Marco, et al.
Publicado: (2023)

Future of biotherapeutics: Harnessing mRNA to enhance elastin expression
por: Crawford, Benjamin C., et al.
Publicado: (2023)

Effectiveness of first-generation severe acute respiratory syndrome coronavirus 2 mRNA vaccines against the Omicron variant
por: Dagan, Noa, et al.
Publicado: (2022)

Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all?
por: Tau, Noam, et al.
Publicado: (2021)

mRNA rescues neonatal acidemia while mice report no aftereffects
por: Zimak, Jan, et al.
Publicado: (2019)

The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
por: Jhaveri, Ravi
Publicado: (2021)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

Presentation matters: Buffers, packaging, and delivery devices for new, oral enteric vaccines for infants
por: Lal, Manjari, et al.
Publicado: (2016)

COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge
por: Sultana, Janet, et al.
Publicado: (2022)

Ubiquitous accumulation of 3′ mRNA decay fragments in Saccharomyces cerevisiae mRNAs with chromosomally integrated MS2 arrays
por: Garcia, Jennifer F., et al.
Publicado: (2016)

mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic
por: Van Lint, Sandra, et al.
Publicado: (2013)

mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine
por: Gao, Xiaoyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hjc0luebnqlogjqbpb4i9dbptd